Clinical Trials Browser

Recurrence × Paclitaxel × 90 days × Clear all

NCT00864318 2026-04-14

TICE

Phase 2 Completed

Neoplasms, Germ Cell and Embryonal, Recurrence

NCT07423078 2026-04-13

WOLF

Phase 2 Recruiting

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

NCT03315364 2026-04-01

OPTIMAL

Phase 2/3 Active not recruiting

Breast Neoplasms, Recurrence

NCT06052839 2026-02-09

Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC

Phase 2 Recruiting

Recurrence